What is the differential diagnosis for a solitary deep cortical central nervous system lesion that enhances with contrast and is surrounded by edema in a non‑HIV patient?

Differential Diagnosis of Single Deep Cortical CNS Enhancing Lesion with Edema in Non-HIV Patient

The differential diagnosis for a solitary deep cortical contrast-enhancing CNS lesion with surrounding edema in a non-HIV patient primarily includes: primary CNS lymphoma (PCNSL), high-grade glioma (particularly glioblastoma), brain metastasis, abscess (including tuberculous), tumefactive demyelination, and neurosarcoidosis.

Primary Diagnostic Considerations

Primary CNS Lymphoma (PCNSL)

PCNSL represents a critical diagnostic consideration for solitary enhancing lesions. Stereotactic biopsy is mandatory for definitive diagnosis, and corticosteroids must be avoided before tissue sampling whenever clinically possible 1. Key imaging features include:

• Hypointense on T1, isointense to hypointense on T2
• Reduced apparent diffusion coefficient (ADC)
• Homogeneous and often strong enhancement
• Variable surrounding edema 1
• Periventricular or superficial location is characteristic 2

Critical pitfall: Corticosteroids cause rapid tumor cell death in PCNSL, potentially leading to false-negative biopsies. If steroids have been started, stop them and repeat MRI before biopsy 1.

High-Grade Glioma (Glioblastoma)

High-grade gliomas, particularly glioblastoma, commonly present as solitary enhancing masses with surrounding edema. MR perfusion with elevated relative cerebral blood volume (rCBV) helps differentiate glioblastoma from lymphoma and metastases 3. Advanced imaging including diffusion-weighted imaging and MR spectroscopy can predict molecular markers like IDH mutation status 3.

Brain Metastasis

Metastatic disease must be considered, especially in patients with known systemic malignancy or risk factors. Percentage signal recovery on DSC-MRI can help differentiate metastasis from glioblastoma, lymphoma, and meningioma 3. Look for:

• History of systemic cancer
• Multiple lesions (though solitary metastases occur)
• Gray-white junction location
• Disproportionate edema relative to lesion size

Infectious Etiologies

Tuberculous brain abscess can mimic neoplastic lesions, even in patients without overt immunosuppression 4. This diagnosis should be considered in patients with:

• History of tuberculosis exposure or prior infection
• Endemic region residence or travel
• Ring-enhancing lesion with central necrosis

Pyogenic abscess and neurocysticercosis 5 also enter the differential, particularly with appropriate epidemiologic risk factors.

Tumefactive Demyelination

Solitary inflammatory demyelinating lesions can present as mass lesions with enhancement and edema 6, 7. Features suggesting demyelination include:

• Incomplete ring enhancement with open ring sign
• Corticosteroid responsiveness
• Age <50 years
• Absence of mass effect disproportionate to lesion size

Neurosarcoidosis

Isolated neurosarcoidosis (INS) can present with solitary enhancing lesions showing chronic granulomatous inflammation 8. FDG-PET/CT may reveal metabolic heterogeneity and assist in lesion characterization when diagnosis is uncertain 8.

Diagnostic Algorithm

1. Obtain contrast-enhanced MRI with advanced sequences: Include diffusion-weighted imaging, perfusion imaging (DSC-MRI), and susceptibility-weighted imaging 3, 1

2. Assess specific imaging characteristics:

   • ADC values (restricted in lymphoma, abscess)
   • Enhancement pattern (homogeneous vs. ring-enhancing)
   • Perfusion characteristics (elevated rCBV in glioblastoma)
   • Location (periventricular favors lymphoma; gray-white junction favors metastasis)

3. Evaluate clinical context:

   • Age (younger patients: consider demyelination)
   • Cancer history (metastasis)
   • Infectious exposures (tuberculosis, endemic parasites)
   • Immunosuppression status

4. Avoid corticosteroids if PCNSL suspected until after tissue diagnosis 1

5. Proceed to stereotactic biopsy for definitive diagnosis 1. This is the gold standard and should not be delayed when diagnosis remains uncertain after imaging.

6. Consider CSF analysis if biopsy is contraindicated: Flow cytometry, MYD88 L265P mutation, IL-10 levels, and IgVH clonality can support PCNSL diagnosis 1

7. Add FDG-PET/CT when structural imaging is inconclusive, particularly to assess for systemic disease or metabolic activity patterns 8

Key Clinical Pitfalls

• Never start corticosteroids empirically without tissue diagnosis if PCNSL is in the differential—this can render biopsy non-diagnostic
• Do not assume single lesion equals single diagnosis—obtain systemic staging if lymphoma or metastasis suspected
• Recognize that infectious etiologies can occur without overt immunosuppression 4
• Advanced MRI techniques (perfusion, spectroscopy) significantly improve diagnostic accuracy but do not replace tissue diagnosis 3